News
LFVN
25.62
+11.39%
2.62
Lifevantage Price Target Announced at $35.00/Share by Craig-Hallum
Dow Jones · 17h ago
Craig-Hallum Initiates Coverage On Lifevantage with Buy Rating, Announces Price Target of $35
Benzinga · 17h ago
Craig-Hallum bullish on LifeVantage, initiates with a Buy
TipRanks · 21h ago
LifeVantage initiated with a Buy at Craig-Hallum
TipRanks · 22h ago
LifeVantage announces results of third-party cell study of health weight stack
TipRanks · 1d ago
LifeVantage launches 2025 vision with ‘Drive ERA’
TipRanks · 1d ago
LifeVantage Announces 2025 Vision At Global Kickoff, Emphasizes MindBody GLP-1 System Expansion, Philippines, Taiwan, Hong Kong, Singapore To Transition To Evolve Plan On March 1, Thailand By Fiscal Year End
Benzinga · 1d ago
LIFEVANTAGE LAUNCHES 2025 VISION WITH “DRIVE ERA” THEME AND INTERNATIONAL EXPANSION PLANS FOR EVOLVE COMPENSATION PLAN AND THE MINDBODY GLP-1 SYSTEM™
Reuters · 1d ago
Weekly Report: what happened at LFVN last week (0106-0110)?
Weekly Report · 2d ago
Undercovered Dozen: Fannie Mae, Civitas Resources, LifeVantage, ZenaTech +
Seeking Alpha · 3d ago
LifeVantage price target raised to $30 from $26 at Lake Street
TipRanks · 4d ago
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
Seeking Alpha · 5d ago
LifeVantage soars after seeing a sales boost from its GLP-1 product
Seeking Alpha · 6d ago
Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
NASDAQ · 6d ago
LifeVantage Shares Rise 30% After 2025 Revenue Outlook Improves
Dow Jones · 6d ago
Morning Movers: AngioDynamics jumps following results and guidance raise
TipRanks · 6d ago
LifeVantage expects Q2 revenue of about $67.5M, raises FY25 sales guidance
Seeking Alpha · 6d ago
Lake Street Remains a Buy on LifeVantage (LFVN)
TipRanks · 6d ago
LifeVantage sees Q2 revenue $67.5M, up 31% vs. last year
TipRanks · 6d ago
LifeVantage raises FY25 revenue view $235M-$245M from $200M-$210M
TipRanks · 6d ago
More
Webull provides a variety of real-time LFVN stock news. You can receive the latest news about Lifevantage Corp through multiple platforms. This information may help you make smarter investment decisions.
About LFVN
LifeVantage Corporation is engaged in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The Company's dietary supplements include its flagship Protandim family of products, LifeVantage Omega+, ProBio, IC Bright, Rise AM, Reset PM, D3+, Daily Wellness, and PhysIQ Fat Burn and Prebiotic dietary supplements. The Protandim product line includes Protandim NRF1 Synergizer, Protandim Nrf2 Synergizer, and Protandim NAD Synergizer. TrueScience is its line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim, its companion pet supplement formulated to combat oxidative stress in dogs, and AXIO, its nootropic energy drink mix. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, Spain, Ireland, Singapore, and the Philippines.